International Clinical Trial: Safety and Tolerability of an Ultra Absorbency Menstrual Tampon Compared to a Commercially Marketed Tampon

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07807891) titled 'Safety and Tolerability of an Ultra Absorbency Menstrual Tampon Compared to a Commercially Marketed Tampon' on Sept. 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Other. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Lyv Life Inc. (dba: Cora)

Condition: Safety and Tolerability in Healthy Volunteers

Intervention: Device: Tampon

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: September 10, 2026

Target Sample Size: 120

Countries of Recruitment: United St...